<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Enriched blood vessels occur in the stroma of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and are related to the ease of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion in the early stage of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-inducible factor (HIF) is closely related with <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> through expression of vascular endothelial growth factor </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the present study was to determine the predictors for <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and evaluate their clinical significance </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Between December 2003 and May 2004, 209 patients with endoscopically and histologically proven <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> were enrolled </plain></SENT>
<SENT sid="4" pm="."><plain>Before endoscopic examination, <z:hpo ids='HP_0000001'>all</z:hpo> participants answered structured questionnaires for <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms and <z:e sem="disease" ids="C0242510" disease_type="Mental or Behavioral Dysfunction" abbrv="">drug usage</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>HIF-1alpha and COX-2 protein expressions, cellular proliferation, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were investigated immunohistochemically in biopsy samples taken from the esophagus of each patient </plain></SENT>
<SENT sid="6" pm="."><plain>The degree of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> was determined by CD34 immunostaining analysis </plain></SENT>
<SENT sid="7" pm="."><plain>Predictors for <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> were evaluated with multivariate logistic regression analysis </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Sixty (28.7%) of the 209 enrolled patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> had a high CD34 score </plain></SENT>
<SENT sid="9" pm="."><plain>Factors proven as positive predictors for a high CD34 score were presence of <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms, reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, COX-2 protein expression, and the proliferating cell nuclear antigen (PCNA) index </plain></SENT>
<SENT sid="10" pm="."><plain>Administration of <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> and HIF-1alpha protein expression were not predictors </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> and <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms were positive predictors for enriched <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in the stromal portion of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, which has malignant potential because the epithelial cells express COX-2 and have accelerated cellular proliferation </plain></SENT>
</text></document>